AEROVIRUS TECH INC has a total of 14 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2015. It filed its patents most often in Canada, EPO (European Patent Office) and United States. Its main competitors in its focus markets biotechnology, pharmaceuticals and measurement are HVIDOVRE HOSPITAL, LABORATORY CORP AMERICA HOLDINGS and NEXSTAR PHARMACEUTICALS INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | Canada | 5 | |
#2 | EPO (European Patent Office) | 3 | |
#3 | United States | 3 | |
#4 | WIPO (World Intellectual Property Organization) | 3 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals | |
#3 | Measurement | |
#4 | Organic fine chemistry | |
#5 | Chemical engineering |
# | Technology | |
---|---|---|
#1 | Analysing materials | |
#2 | Measuring microorganism processes | |
#3 | Peptides | |
#4 | Microorganisms | |
#5 | Therapeutic chemical compounds | |
#6 | Medical preparations | |
#7 | Sugars | |
#8 | Chemical or physical laboratory devices |
# | Name | Total Patents |
---|---|---|
#1 | Liao Albert | 9 |
#2 | Caltagirone G Thomas | 8 |
#3 | Marchand Norman | 8 |
#4 | Marchand Norman J | 6 |
#5 | Graziano Carmine | 4 |
#6 | Lioa Albert | 1 |
#7 | Caltagirone Thomas G | 1 |
#8 | Caltagirone Thomas | 1 |
Publication | Filing date | Title |
---|---|---|
EP3512933A1 | Device and method for real-time detection of aeropathogens | |
CA2940637A1 | Aptamers, nucleic acid molecules, synthetic antibodies and compositions for detecting mycoplasma hyopneumoniae and treating mycoplasma hyopneumoniae infection | |
CA2914337A1 | Aptamers, nucleic acid molecules, polynucleotides, synthetic antibodies compositions for detecting prrs viruses and treating prrs virus infection | |
CA2898714A1 | Device and method for real-time detection of aeropathogens |